nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—endogenous depression—Amitriptyline—migraine	0.2	0.54	CpDpCtD
Vilazodone—endogenous depression—Valproic Acid—migraine	0.17	0.46	CpDpCtD
Vilazodone—HTR1A—migraine	0.156	0.539	CbGaD
Vilazodone—SLC6A4—migraine	0.133	0.46	CbGaD
Vilazodone—CYP2C18—Valproic Acid—migraine	0.0442	0.17	CbGbCtD
Vilazodone—CYP2C18—Verapamil—migraine	0.0385	0.148	CbGbCtD
Vilazodone—SLC6A4—Amitriptyline—migraine	0.0296	0.114	CbGbCtD
Vilazodone—HTR1A—Propranolol—migraine	0.027	0.104	CbGbCtD
Vilazodone—SLC6A4—Verapamil—migraine	0.0235	0.0902	CbGbCtD
Vilazodone—HTR1A—Amitriptyline—migraine	0.0233	0.0896	CbGbCtD
Vilazodone—DRD2—Amitriptyline—migraine	0.0205	0.0789	CbGbCtD
Vilazodone—CYP2D6—Timolol—migraine	0.00962	0.037	CbGbCtD
Vilazodone—CYP2D6—Propranolol—migraine	0.00858	0.033	CbGbCtD
Vilazodone—CYP2D6—Amitriptyline—migraine	0.00742	0.0285	CbGbCtD
Vilazodone—CYP2D6—Verapamil—migraine	0.00589	0.0226	CbGbCtD
Vilazodone—CYP3A4—Propranolol—migraine	0.00545	0.021	CbGbCtD
Vilazodone—CYP3A4—Amitriptyline—migraine	0.00472	0.0181	CbGbCtD
Vilazodone—CYP3A4—Valproic Acid—migraine	0.0043	0.0165	CbGbCtD
Vilazodone—CYP3A4—Topiramate—migraine	0.00388	0.0149	CbGbCtD
Vilazodone—CYP3A4—Verapamil—migraine	0.00374	0.0144	CbGbCtD
Vilazodone—HTR1A—Serotonin receptors—HTR1D—migraine	0.00114	0.0549	CbGpPWpGaD
Vilazodone—HTR1A—Serotonin receptors—HTR2B—migraine	0.00106	0.0511	CbGpPWpGaD
Vilazodone—SLC6A4—Synaptic Vesicle Pathway—ATP1A2—migraine	0.000744	0.0358	CbGpPWpGaD
Vilazodone—HTR1A—Serotonin receptors—HTR1B—migraine	0.000693	0.0333	CbGpPWpGaD
Vilazodone—HTR1A—Serotonin receptors—HTR2C—migraine	0.000644	0.0309	CbGpPWpGaD
Vilazodone—HTR1A—Serotonin receptors—HTR7—migraine	0.000564	0.0271	CbGpPWpGaD
Vilazodone—Sexual dysfunction—Gabapentin—migraine	0.000563	0.00985	CcSEcCtD
Vilazodone—Libido decreased—Amitriptyline—migraine	0.000562	0.00982	CcSEcCtD
Vilazodone—Suicide attempt—Gabapentin—migraine	0.000557	0.00973	CcSEcCtD
Vilazodone—Dry eye—Propranolol—migraine	0.00054	0.00943	CcSEcCtD
Vilazodone—SLC6A4—Synaptic Vesicle Pathway—CACNA1A—migraine	0.000538	0.0258	CbGpPWpGaD
Vilazodone—Completed suicide—Gabapentin—migraine	0.000537	0.00939	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Amitriptyline—migraine	0.000517	0.00903	CcSEcCtD
Vilazodone—Suicide—Topiramate—migraine	0.000512	0.00895	CcSEcCtD
Vilazodone—HTR1A—Monoamine GPCRs—HTR1D—migraine	0.000509	0.0245	CbGpPWpGaD
Vilazodone—Irritability—Amitriptyline—migraine	0.000497	0.00869	CcSEcCtD
Vilazodone—Sexual dysfunction—Topiramate—migraine	0.000474	0.00828	CcSEcCtD
Vilazodone—HTR1A—Monoamine GPCRs—HTR2B—migraine	0.000473	0.0227	CbGpPWpGaD
Vilazodone—Suicide attempt—Topiramate—migraine	0.000468	0.00818	CcSEcCtD
Vilazodone—Completed suicide—Topiramate—migraine	0.000452	0.0079	CcSEcCtD
Vilazodone—DRD2—Monoamine GPCRs—HTR1D—migraine	0.000447	0.0215	CbGpPWpGaD
Vilazodone—Mania—Gabapentin—migraine	0.000434	0.00759	CcSEcCtD
Vilazodone—HTR1A—Amine ligand-binding receptors—HTR1D—migraine	0.000428	0.0206	CbGpPWpGaD
Vilazodone—Pollakiuria—Amitriptyline—migraine	0.000416	0.00727	CcSEcCtD
Vilazodone—DRD2—Monoamine GPCRs—HTR2B—migraine	0.000416	0.02	CbGpPWpGaD
Vilazodone—Erectile dysfunction—Amitriptyline—migraine	0.000415	0.00725	CcSEcCtD
Vilazodone—Irritability—Propranolol—migraine	0.000405	0.00707	CcSEcCtD
Vilazodone—HTR1A—Amine ligand-binding receptors—HTR2B—migraine	0.000398	0.0191	CbGpPWpGaD
Vilazodone—HTR1A—Serotonin receptors—HTR2A—migraine	0.000395	0.019	CbGpPWpGaD
Vilazodone—Suicidal ideation—Topiramate—migraine	0.000379	0.00662	CcSEcCtD
Vilazodone—Aripiprazole—HTR3A—migraine	0.000378	0.119	CrCbGaD
Vilazodone—Abnormal dreams—Valproic Acid—migraine	0.000377	0.00658	CcSEcCtD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR1D—migraine	0.000376	0.0181	CbGpPWpGaD
Vilazodone—Aripiprazole—HTR1D—migraine	0.000374	0.118	CrCbGaD
Vilazodone—Aripiprazole—HTR2B—migraine	0.00037	0.116	CrCbGaD
Vilazodone—Trazodone—HTR2B—migraine	0.000368	0.116	CrCbGaD
Vilazodone—Mania—Topiramate—migraine	0.000365	0.00639	CcSEcCtD
Vilazodone—Hallucination—Amitriptyline—migraine	0.000358	0.00626	CcSEcCtD
Vilazodone—Cataract—Timolol—migraine	0.000356	0.00623	CcSEcCtD
Vilazodone—Dry eye—Valproic Acid—migraine	0.000352	0.00615	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Gabapentin—migraine	0.00035	0.00611	CcSEcCtD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR2B—migraine	0.000349	0.0168	CbGpPWpGaD
Vilazodone—Erectile dysfunction—Propranolol—migraine	0.000338	0.0059	CcSEcCtD
Vilazodone—Abnormal dreams—Timolol—migraine	0.000335	0.00586	CcSEcCtD
Vilazodone—Cataract—Gabapentin—migraine	0.000332	0.0058	CcSEcCtD
Vilazodone—Dry eye—Timolol—migraine	0.000313	0.00547	CcSEcCtD
Vilazodone—Abnormal dreams—Gabapentin—migraine	0.000312	0.00546	CcSEcCtD
Vilazodone—Gastroenteritis—Valproic Acid—migraine	0.000312	0.00545	CcSEcCtD
Vilazodone—Pollakiuria—Verapamil—migraine	0.000311	0.00544	CcSEcCtD
Vilazodone—Erectile dysfunction—Verapamil—migraine	0.000311	0.00543	CcSEcCtD
Vilazodone—HTR1A—Monoamine GPCRs—HTR1B—migraine	0.000309	0.0148	CbGpPWpGaD
Vilazodone—Dysgeusia—Amitriptyline—migraine	0.000307	0.00537	CcSEcCtD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000304	0.0146	CbGpPWpGaD
Vilazodone—Vision blurred—Amitriptyline—migraine	0.000296	0.00517	CcSEcCtD
Vilazodone—Increased appetite—Valproic Acid—migraine	0.000294	0.00514	CcSEcCtD
Vilazodone—Tremor—Amitriptyline—migraine	0.000294	0.00514	CcSEcCtD
Vilazodone—Hallucination—Propranolol—migraine	0.000292	0.0051	CcSEcCtD
Vilazodone—Dry eye—Gabapentin—migraine	0.000292	0.0051	CcSEcCtD
Vilazodone—Agitation—Amitriptyline—migraine	0.000288	0.00504	CcSEcCtD
Vilazodone—HTR1A—Monoamine GPCRs—HTR2C—migraine	0.000287	0.0138	CbGpPWpGaD
Vilazodone—Hyponatraemia—Valproic Acid—migraine	0.000278	0.00485	CcSEcCtD
Vilazodone—Palpitations—Amitriptyline—migraine	0.000277	0.00484	CcSEcCtD
Vilazodone—Cardiac disorder—Propranolol—migraine	0.000272	0.00476	CcSEcCtD
Vilazodone—Convulsion—Amitriptyline—migraine	0.000272	0.00475	CcSEcCtD
Vilazodone—DRD2—Monoamine GPCRs—HTR1B—migraine	0.000271	0.013	CbGpPWpGaD
Vilazodone—Libido decreased—Timolol—migraine	0.000266	0.00464	CcSEcCtD
Vilazodone—Dry mouth—Amitriptyline—migraine	0.000261	0.00456	CcSEcCtD
Vilazodone—DRD2—Monoamine GPCRs—HTR1A—migraine	0.000261	0.0125	CbGpPWpGaD
Vilazodone—HTR1A—Amine ligand-binding receptors—HTR1B—migraine	0.000259	0.0125	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—HTR3A—migraine	0.000259	0.0124	CbGpPWpGaD
Vilazodone—Gastroenteritis—Gabapentin—migraine	0.000259	0.00452	CcSEcCtD
Vilazodone—Mental disorder—Propranolol—migraine	0.000257	0.00449	CcSEcCtD
Vilazodone—DRD2—Monoamine GPCRs—HTR2C—migraine	0.000252	0.0121	CbGpPWpGaD
Vilazodone—HTR1A—Monoamine GPCRs—HTR7—migraine	0.000251	0.0121	CbGpPWpGaD
Vilazodone—Breast disorder—Valproic Acid—migraine	0.00025	0.00437	CcSEcCtD
Vilazodone—Hyperhidrosis—Amitriptyline—migraine	0.000247	0.00432	CcSEcCtD
Vilazodone—Libido decreased—Gabapentin—migraine	0.000247	0.00432	CcSEcCtD
Vilazodone—Dry eye—Topiramate—migraine	0.000245	0.00429	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Timolol—migraine	0.000244	0.00427	CcSEcCtD
Vilazodone—Increased appetite—Gabapentin—migraine	0.000244	0.00426	CcSEcCtD
Vilazodone—HTR1A—Amine ligand-binding receptors—HTR2C—migraine	0.000241	0.0116	CbGpPWpGaD
Vilazodone—Agitation—Propranolol—migraine	0.000235	0.0041	CcSEcCtD
Vilazodone—Insomnia—Amitriptyline—migraine	0.000232	0.00405	CcSEcCtD
Vilazodone—Hyponatraemia—Gabapentin—migraine	0.00023	0.00402	CcSEcCtD
Vilazodone—Paraesthesia—Amitriptyline—migraine	0.00023	0.00402	CcSEcCtD
Vilazodone—Aripiprazole—HTR7—migraine	0.000229	0.072	CrCbGaD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR1B—migraine	0.000228	0.0109	CbGpPWpGaD
Vilazodone—Somnolence—Amitriptyline—migraine	0.000228	0.00398	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Gabapentin—migraine	0.000227	0.00398	CcSEcCtD
Vilazodone—Migraine—Gabapentin—migraine	0.000226	0.00394	CcSEcCtD
Vilazodone—Dyspepsia—Amitriptyline—migraine	0.000225	0.00394	CcSEcCtD
Vilazodone—Decreased appetite—Amitriptyline—migraine	0.000223	0.00389	CcSEcCtD
Vilazodone—Breast disorder—Timolol—migraine	0.000223	0.00389	CcSEcCtD
Vilazodone—Aripiprazole—HTR1B—migraine	0.000222	0.0697	CrCbGaD
Vilazodone—Vision blurred—Verapamil—migraine	0.000221	0.00387	CcSEcCtD
Vilazodone—Convulsion—Propranolol—migraine	0.000221	0.00387	CcSEcCtD
Vilazodone—Pollakiuria—Valproic Acid—migraine	0.000221	0.00386	CcSEcCtD
Vilazodone—Fatigue—Amitriptyline—migraine	0.000221	0.00386	CcSEcCtD
Vilazodone—DRD2—Monoamine GPCRs—HTR7—migraine	0.000221	0.0106	CbGpPWpGaD
Vilazodone—Tremor—Verapamil—migraine	0.00022	0.00385	CcSEcCtD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR1A—migraine	0.000219	0.0105	CbGpPWpGaD
Vilazodone—Irritability—Gabapentin—migraine	0.000219	0.00382	CcSEcCtD
Vilazodone—Gastroenteritis—Topiramate—migraine	0.000218	0.0038	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000216	0.00377	CcSEcCtD
Vilazodone—Agitation—Verapamil—migraine	0.000216	0.00377	CcSEcCtD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000212	0.0102	CbGpPWpGaD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR2C—migraine	0.000212	0.0102	CbGpPWpGaD
Vilazodone—HTR1A—Amine ligand-binding receptors—HTR7—migraine	0.000211	0.0101	CbGpPWpGaD
Vilazodone—Feeling abnormal—Amitriptyline—migraine	0.000211	0.00369	CcSEcCtD
Vilazodone—Libido decreased—Topiramate—migraine	0.000208	0.00364	CcSEcCtD
Vilazodone—Palpitations—Verapamil—migraine	0.000208	0.00363	CcSEcCtD
Vilazodone—Breast disorder—Gabapentin—migraine	0.000207	0.00362	CcSEcCtD
Vilazodone—Increased appetite—Topiramate—migraine	0.000205	0.00359	CcSEcCtD
Vilazodone—Nervous system disorder—Propranolol—migraine	0.000204	0.00357	CcSEcCtD
Vilazodone—Convulsion—Verapamil—migraine	0.000204	0.00356	CcSEcCtD
Vilazodone—Skin disorder—Propranolol—migraine	0.000202	0.00354	CcSEcCtD
Vilazodone—Arthralgia—Verapamil—migraine	0.0002	0.0035	CcSEcCtD
Vilazodone—Erectile dysfunction—Timolol—migraine	0.000196	0.00343	CcSEcCtD
Vilazodone—Dry mouth—Verapamil—migraine	0.000196	0.00342	CcSEcCtD
Vilazodone—Hyponatraemia—Topiramate—migraine	0.000194	0.00338	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Topiramate—migraine	0.000191	0.00334	CcSEcCtD
Vilazodone—Hallucination—Valproic Acid—migraine	0.00019	0.00333	CcSEcCtD
Vilazodone—Migraine—Topiramate—migraine	0.00019	0.00332	CcSEcCtD
Vilazodone—Insomnia—Propranolol—migraine	0.000189	0.00329	CcSEcCtD
Vilazodone—Connective tissue disorder—Valproic Acid—migraine	0.000188	0.00329	CcSEcCtD
Vilazodone—Paraesthesia—Propranolol—migraine	0.000187	0.00327	CcSEcCtD
Vilazodone—CYP2C18—FOXA1 transcription factor network—ESR1—migraine	0.000186	0.00893	CbGpPWpGaD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR7—migraine	0.000185	0.00891	CbGpPWpGaD
Vilazodone—Hyperhidrosis—Verapamil—migraine	0.000185	0.00324	CcSEcCtD
Vilazodone—Somnolence—Propranolol—migraine	0.000185	0.00324	CcSEcCtD
Vilazodone—Irritability—Topiramate—migraine	0.000184	0.00322	CcSEcCtD
Vilazodone—Asthenia—Amitriptyline—migraine	0.000184	0.00321	CcSEcCtD
Vilazodone—Dyspepsia—Propranolol—migraine	0.000183	0.00321	CcSEcCtD
Vilazodone—Pollakiuria—Gabapentin—migraine	0.000183	0.0032	CcSEcCtD
Vilazodone—Erectile dysfunction—Gabapentin—migraine	0.000183	0.00319	CcSEcCtD
Vilazodone—Decreased appetite—Propranolol—migraine	0.000181	0.00317	CcSEcCtD
Vilazodone—Aripiprazole—HTR2C—migraine	0.000181	0.0568	CrCbGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—HTR3A—migraine	0.00018	0.00866	CbGpPWpGaD
Vilazodone—Trazodone—HTR2C—migraine	0.00018	0.0566	CrCbGaD
Vilazodone—Gastrointestinal disorder—Propranolol—migraine	0.00018	0.00314	CcSEcCtD
Vilazodone—Fatigue—Propranolol—migraine	0.00018	0.00314	CcSEcCtD
Vilazodone—Eye disorder—Valproic Acid—migraine	0.000179	0.00312	CcSEcCtD
Vilazodone—HTR1A—Monoamine GPCRs—HTR2A—migraine	0.000176	0.00845	CbGpPWpGaD
Vilazodone—Aripiprazole—HTR1A—migraine	0.000176	0.0552	CrCbGaD
Vilazodone—Diarrhoea—Amitriptyline—migraine	0.000175	0.00306	CcSEcCtD
Vilazodone—Trazodone—HTR1A—migraine	0.000175	0.0549	CrCbGaD
Vilazodone—Musculoskeletal discomfort—Verapamil—migraine	0.000175	0.00305	CcSEcCtD
Vilazodone—Breast disorder—Topiramate—migraine	0.000174	0.00305	CcSEcCtD
Vilazodone—Insomnia—Verapamil—migraine	0.000173	0.00303	CcSEcCtD
Vilazodone—Paraesthesia—Verapamil—migraine	0.000172	0.00301	CcSEcCtD
Vilazodone—Somnolence—Verapamil—migraine	0.00017	0.00298	CcSEcCtD
Vilazodone—Hallucination—Timolol—migraine	0.000169	0.00296	CcSEcCtD
Vilazodone—Dizziness—Amitriptyline—migraine	0.000169	0.00296	CcSEcCtD
Vilazodone—Dyspepsia—Verapamil—migraine	0.000169	0.00295	CcSEcCtD
Vilazodone—Mental disorder—Valproic Acid—migraine	0.000168	0.00293	CcSEcCtD
Vilazodone—CYP2C18—FOXA1 transcription factor network—FOS—migraine	0.000168	0.00805	CbGpPWpGaD
Vilazodone—Connective tissue disorder—Timolol—migraine	0.000167	0.00293	CcSEcCtD
Vilazodone—Malnutrition—Valproic Acid—migraine	0.000167	0.00291	CcSEcCtD
Vilazodone—Fatigue—Verapamil—migraine	0.000165	0.00289	CcSEcCtD
Vilazodone—Flatulence—Valproic Acid—migraine	0.000164	0.00287	CcSEcCtD
Vilazodone—Dysgeusia—Valproic Acid—migraine	0.000163	0.00285	CcSEcCtD
Vilazodone—Vomiting—Amitriptyline—migraine	0.000163	0.00284	CcSEcCtD
Vilazodone—Nervousness—Valproic Acid—migraine	0.000162	0.00283	CcSEcCtD
Vilazodone—Eye disorder—Timolol—migraine	0.000159	0.00278	CcSEcCtD
Vilazodone—Cardiac disorder—Timolol—migraine	0.000158	0.00276	CcSEcCtD
Vilazodone—Feeling abnormal—Verapamil—migraine	0.000158	0.00276	CcSEcCtD
Vilazodone—Hallucination—Gabapentin—migraine	0.000158	0.00276	CcSEcCtD
Vilazodone—Vision blurred—Valproic Acid—migraine	0.000157	0.00274	CcSEcCtD
Vilazodone—Tremor—Valproic Acid—migraine	0.000156	0.00273	CcSEcCtD
Vilazodone—Connective tissue disorder—Gabapentin—migraine	0.000156	0.00272	CcSEcCtD
Vilazodone—DRD2—Monoamine GPCRs—HTR2A—migraine	0.000154	0.00742	CbGpPWpGaD
Vilazodone—Pollakiuria—Topiramate—migraine	0.000154	0.00269	CcSEcCtD
Vilazodone—Erectile dysfunction—Topiramate—migraine	0.000154	0.00268	CcSEcCtD
Vilazodone—Agitation—Valproic Acid—migraine	0.000153	0.00267	CcSEcCtD
Vilazodone—Nausea—Amitriptyline—migraine	0.000152	0.00266	CcSEcCtD
Vilazodone—Aripiprazole—SLC6A4—migraine	0.00015	0.0471	CrCbGaD
Vilazodone—Asthenia—Propranolol—migraine	0.00015	0.00261	CcSEcCtD
Vilazodone—Mental disorder—Timolol—migraine	0.000149	0.00261	CcSEcCtD
Vilazodone—Trazodone—SLC6A4—migraine	0.000149	0.0469	CrCbGaD
Vilazodone—Malnutrition—Timolol—migraine	0.000148	0.00259	CcSEcCtD
Vilazodone—Eye disorder—Gabapentin—migraine	0.000148	0.00259	CcSEcCtD
Vilazodone—HTR1A—Amine ligand-binding receptors—HTR2A—migraine	0.000148	0.0071	CbGpPWpGaD
Vilazodone—Cardiac disorder—Gabapentin—migraine	0.000147	0.00257	CcSEcCtD
Vilazodone—Palpitations—Valproic Acid—migraine	0.000147	0.00257	CcSEcCtD
Vilazodone—Dysgeusia—Timolol—migraine	0.000145	0.00254	CcSEcCtD
Vilazodone—Nervousness—Timolol—migraine	0.000144	0.00252	CcSEcCtD
Vilazodone—Diarrhoea—Propranolol—migraine	0.000143	0.00249	CcSEcCtD
Vilazodone—Arthralgia—Valproic Acid—migraine	0.000142	0.00248	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000141	0.00246	CcSEcCtD
Vilazodone—Vision blurred—Timolol—migraine	0.00014	0.00244	CcSEcCtD
Vilazodone—Mental disorder—Gabapentin—migraine	0.000139	0.00243	CcSEcCtD
Vilazodone—Dry mouth—Valproic Acid—migraine	0.000139	0.00242	CcSEcCtD
Vilazodone—Malnutrition—Gabapentin—migraine	0.000138	0.00241	CcSEcCtD
Vilazodone—Dizziness—Propranolol—migraine	0.000138	0.00241	CcSEcCtD
Vilazodone—Asthenia—Verapamil—migraine	0.000138	0.0024	CcSEcCtD
Vilazodone—Flatulence—Gabapentin—migraine	0.000136	0.00238	CcSEcCtD
Vilazodone—Dysgeusia—Gabapentin—migraine	0.000135	0.00236	CcSEcCtD
Vilazodone—Nervousness—Gabapentin—migraine	0.000134	0.00234	CcSEcCtD
Vilazodone—Nervous system disorder—Valproic Acid—migraine	0.000133	0.00233	CcSEcCtD
Vilazodone—Hallucination—Topiramate—migraine	0.000133	0.00232	CcSEcCtD
Vilazodone—Vomiting—Propranolol—migraine	0.000133	0.00232	CcSEcCtD
Vilazodone—Skin disorder—Valproic Acid—migraine	0.000132	0.00231	CcSEcCtD
Vilazodone—Hyperhidrosis—Valproic Acid—migraine	0.000131	0.0023	CcSEcCtD
Vilazodone—Diarrhoea—Verapamil—migraine	0.000131	0.00229	CcSEcCtD
Vilazodone—Connective tissue disorder—Topiramate—migraine	0.000131	0.00229	CcSEcCtD
Vilazodone—Palpitations—Timolol—migraine	0.000131	0.00229	CcSEcCtD
Vilazodone—Vision blurred—Gabapentin—migraine	0.00013	0.00227	CcSEcCtD
Vilazodone—DRD2—Amine ligand-binding receptors—HTR2A—migraine	0.00013	0.00624	CbGpPWpGaD
Vilazodone—Tremor—Gabapentin—migraine	0.000129	0.00226	CcSEcCtD
Vilazodone—Agitation—Gabapentin—migraine	0.000127	0.00222	CcSEcCtD
Vilazodone—Dizziness—Verapamil—migraine	0.000127	0.00222	CcSEcCtD
Vilazodone—Arthralgia—Timolol—migraine	0.000126	0.00221	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000125	0.00219	CcSEcCtD
Vilazodone—Eye disorder—Topiramate—migraine	0.000125	0.00218	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Valproic Acid—migraine	0.000124	0.00216	CcSEcCtD
Vilazodone—Cardiac disorder—Topiramate—migraine	0.000124	0.00216	CcSEcCtD
Vilazodone—Nausea—Propranolol—migraine	0.000124	0.00216	CcSEcCtD
Vilazodone—Dry mouth—Timolol—migraine	0.000123	0.00216	CcSEcCtD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—HTR1A—migraine	0.000123	0.00591	CbGpPWpGaD
Vilazodone—Insomnia—Valproic Acid—migraine	0.000123	0.00215	CcSEcCtD
Vilazodone—Paraesthesia—Valproic Acid—migraine	0.000122	0.00213	CcSEcCtD
Vilazodone—Palpitations—Gabapentin—migraine	0.000122	0.00213	CcSEcCtD
Vilazodone—Vomiting—Verapamil—migraine	0.000122	0.00213	CcSEcCtD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—TAC1—migraine	0.000121	0.00582	CbGpPWpGaD
Vilazodone—Somnolence—Valproic Acid—migraine	0.000121	0.00211	CcSEcCtD
Vilazodone—Dyspepsia—Valproic Acid—migraine	0.00012	0.00209	CcSEcCtD
Vilazodone—Convulsion—Gabapentin—migraine	0.00012	0.00209	CcSEcCtD
Vilazodone—Nervous system disorder—Timolol—migraine	0.000119	0.00207	CcSEcCtD
Vilazodone—Decreased appetite—Valproic Acid—migraine	0.000118	0.00207	CcSEcCtD
Vilazodone—Arthralgia—Gabapentin—migraine	0.000118	0.00205	CcSEcCtD
Vilazodone—Skin disorder—Timolol—migraine	0.000118	0.00205	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Valproic Acid—migraine	0.000117	0.00205	CcSEcCtD
Vilazodone—Fatigue—Valproic Acid—migraine	0.000117	0.00205	CcSEcCtD
Vilazodone—Hyperhidrosis—Timolol—migraine	0.000117	0.00204	CcSEcCtD
Vilazodone—Mental disorder—Topiramate—migraine	0.000117	0.00204	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000117	0.00204	CcSEcCtD
Vilazodone—Malnutrition—Topiramate—migraine	0.000116	0.00203	CcSEcCtD
Vilazodone—Aripiprazole—HTR2A—migraine	0.000115	0.0362	CrCbGaD
Vilazodone—Dry mouth—Gabapentin—migraine	0.000115	0.00201	CcSEcCtD
Vilazodone—Trazodone—HTR2A—migraine	0.000115	0.036	CrCbGaD
Vilazodone—Flatulence—Topiramate—migraine	0.000114	0.002	CcSEcCtD
Vilazodone—Nausea—Verapamil—migraine	0.000114	0.00199	CcSEcCtD
Vilazodone—Dysgeusia—Topiramate—migraine	0.000114	0.00199	CcSEcCtD
Vilazodone—Nervousness—Topiramate—migraine	0.000113	0.00197	CcSEcCtD
Vilazodone—Feeling abnormal—Valproic Acid—migraine	0.000112	0.00196	CcSEcCtD
Vilazodone—SLC6A4—Monoamine Transport—TNF—migraine	0.000111	0.00535	CbGpPWpGaD
Vilazodone—Nervous system disorder—Gabapentin—migraine	0.000111	0.00193	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Timolol—migraine	0.00011	0.00193	CcSEcCtD
Vilazodone—Vision blurred—Topiramate—migraine	0.000109	0.00191	CcSEcCtD
Vilazodone—Skin disorder—Gabapentin—migraine	0.000109	0.00191	CcSEcCtD
Vilazodone—Insomnia—Timolol—migraine	0.000109	0.00191	CcSEcCtD
Vilazodone—Hyperhidrosis—Gabapentin—migraine	0.000109	0.0019	CcSEcCtD
Vilazodone—Tremor—Topiramate—migraine	0.000109	0.0019	CcSEcCtD
Vilazodone—Paraesthesia—Timolol—migraine	0.000109	0.0019	CcSEcCtD
Vilazodone—Somnolence—Timolol—migraine	0.000108	0.00188	CcSEcCtD
Vilazodone—Agitation—Topiramate—migraine	0.000107	0.00187	CcSEcCtD
Vilazodone—Dyspepsia—Timolol—migraine	0.000107	0.00186	CcSEcCtD
Vilazodone—HTR1A—G alpha (i) signalling events—HTR1D—migraine	0.000106	0.00509	CbGpPWpGaD
Vilazodone—Decreased appetite—Timolol—migraine	0.000105	0.00184	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Timolol—migraine	0.000104	0.00183	CcSEcCtD
Vilazodone—Fatigue—Timolol—migraine	0.000104	0.00182	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Gabapentin—migraine	0.000103	0.00179	CcSEcCtD
Vilazodone—Palpitations—Topiramate—migraine	0.000103	0.00179	CcSEcCtD
Vilazodone—Insomnia—Gabapentin—migraine	0.000102	0.00178	CcSEcCtD
Vilazodone—Paraesthesia—Gabapentin—migraine	0.000101	0.00177	CcSEcCtD
Vilazodone—Convulsion—Topiramate—migraine	0.000101	0.00176	CcSEcCtD
Vilazodone—Somnolence—Gabapentin—migraine	0.0001	0.00175	CcSEcCtD
Vilazodone—Feeling abnormal—Timolol—migraine	9.97e-05	0.00174	CcSEcCtD
Vilazodone—Dyspepsia—Gabapentin—migraine	9.92e-05	0.00173	CcSEcCtD
Vilazodone—SLC6A4—Circadian rythm related genes—NPS—migraine	9.89e-05	0.00475	CbGpPWpGaD
Vilazodone—Arthralgia—Topiramate—migraine	9.89e-05	0.00173	CcSEcCtD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	9.83e-05	0.00472	CbGpPWpGaD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	9.82e-05	0.00172	CcSEcCtD
Vilazodone—Decreased appetite—Gabapentin—migraine	9.8e-05	0.00171	CcSEcCtD
Vilazodone—Asthenia—Valproic Acid—migraine	9.75e-05	0.0017	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Gabapentin—migraine	9.73e-05	0.0017	CcSEcCtD
Vilazodone—Fatigue—Gabapentin—migraine	9.72e-05	0.0017	CcSEcCtD
Vilazodone—Dry mouth—Topiramate—migraine	9.67e-05	0.00169	CcSEcCtD
Vilazodone—SLC6A4—NRF2 pathway—TGFBR2—migraine	9.45e-05	0.00454	CbGpPWpGaD
Vilazodone—Diarrhoea—Valproic Acid—migraine	9.3e-05	0.00163	CcSEcCtD
Vilazodone—DRD2—G alpha (i) signalling events—HTR1D—migraine	9.3e-05	0.00447	CbGpPWpGaD
Vilazodone—Nervous system disorder—Topiramate—migraine	9.3e-05	0.00162	CcSEcCtD
Vilazodone—Feeling abnormal—Gabapentin—migraine	9.29e-05	0.00162	CcSEcCtD
Vilazodone—Skin disorder—Topiramate—migraine	9.21e-05	0.00161	CcSEcCtD
Vilazodone—Hyperhidrosis—Topiramate—migraine	9.17e-05	0.0016	CcSEcCtD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	9.14e-05	0.00439	CbGpPWpGaD
Vilazodone—Dizziness—Valproic Acid—migraine	8.99e-05	0.00157	CcSEcCtD
Vilazodone—HTR1A—GPCR ligand binding—CALCRL—migraine	8.83e-05	0.00424	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—RAMP1—migraine	8.83e-05	0.00424	CbGpPWpGaD
Vilazodone—Asthenia—Timolol—migraine	8.68e-05	0.00152	CcSEcCtD
Vilazodone—Vomiting—Valproic Acid—migraine	8.64e-05	0.00151	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Topiramate—migraine	8.64e-05	0.00151	CcSEcCtD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	8.63e-05	0.00414	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—BDNF—migraine	8.63e-05	0.00414	CbGpPWpGaD
Vilazodone—Insomnia—Topiramate—migraine	8.58e-05	0.0015	CcSEcCtD
Vilazodone—Paraesthesia—Topiramate—migraine	8.51e-05	0.00149	CcSEcCtD
Vilazodone—SLC6A4—Circadian rythm related genes—HTR7—migraine	8.5e-05	0.00408	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—TAC1—migraine	8.44e-05	0.00405	CbGpPWpGaD
Vilazodone—Somnolence—Topiramate—migraine	8.43e-05	0.00147	CcSEcCtD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	8.42e-05	0.00404	CbGpPWpGaD
Vilazodone—Dyspepsia—Topiramate—migraine	8.35e-05	0.00146	CcSEcCtD
Vilazodone—Diarrhoea—Timolol—migraine	8.28e-05	0.00145	CcSEcCtD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—SLC6A4—migraine	8.28e-05	0.00398	CbGpPWpGaD
Vilazodone—Decreased appetite—Topiramate—migraine	8.24e-05	0.00144	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Topiramate—migraine	8.19e-05	0.00143	CcSEcCtD
Vilazodone—Fatigue—Topiramate—migraine	8.17e-05	0.00143	CcSEcCtD
Vilazodone—Asthenia—Gabapentin—migraine	8.09e-05	0.00141	CcSEcCtD
Vilazodone—Nausea—Valproic Acid—migraine	8.07e-05	0.00141	CcSEcCtD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	8.02e-05	0.00385	CbGpPWpGaD
Vilazodone—Dizziness—Timolol—migraine	8e-05	0.0014	CcSEcCtD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	7.83e-05	0.00376	CbGpPWpGaD
Vilazodone—Feeling abnormal—Topiramate—migraine	7.81e-05	0.00137	CcSEcCtD
Vilazodone—DRD2—GPCR ligand binding—RAMP1—migraine	7.75e-05	0.00372	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CALCRL—migraine	7.75e-05	0.00372	CbGpPWpGaD
Vilazodone—Diarrhoea—Gabapentin—migraine	7.71e-05	0.00135	CcSEcCtD
Vilazodone—Vomiting—Timolol—migraine	7.69e-05	0.00134	CcSEcCtD
Vilazodone—Dizziness—Gabapentin—migraine	7.45e-05	0.0013	CcSEcCtD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	7.39e-05	0.00355	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—HTR2A—migraine	7.29e-05	0.0035	CbGpPWpGaD
Vilazodone—Nausea—Timolol—migraine	7.19e-05	0.00126	CcSEcCtD
Vilazodone—Vomiting—Gabapentin—migraine	7.17e-05	0.00125	CcSEcCtD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	6.87e-05	0.0033	CbGpPWpGaD
Vilazodone—Asthenia—Topiramate—migraine	6.8e-05	0.00119	CcSEcCtD
Vilazodone—Nausea—Gabapentin—migraine	6.69e-05	0.00117	CcSEcCtD
Vilazodone—Diarrhoea—Topiramate—migraine	6.49e-05	0.00113	CcSEcCtD
Vilazodone—HTR1A—G alpha (i) signalling events—HTR1B—migraine	6.42e-05	0.00308	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR1D—migraine	6.41e-05	0.00308	CbGpPWpGaD
Vilazodone—Dizziness—Topiramate—migraine	6.27e-05	0.0011	CcSEcCtD
Vilazodone—DRD2—Circadian rythm related genes—NPS—migraine	6.05e-05	0.00291	CbGpPWpGaD
Vilazodone—Vomiting—Topiramate—migraine	6.03e-05	0.00105	CcSEcCtD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—BDNF—migraine	6.01e-05	0.00289	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR2B—migraine	5.96e-05	0.00286	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	5.95e-05	0.00286	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—SLC6A4—migraine	5.93e-05	0.00285	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—HTR1B—migraine	5.63e-05	0.00271	CbGpPWpGaD
Vilazodone—Nausea—Topiramate—migraine	5.63e-05	0.000984	CcSEcCtD
Vilazodone—DRD2—GPCR ligand binding—HTR1D—migraine	5.63e-05	0.0027	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	5.54e-05	0.00266	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—HTR1A—migraine	5.42e-05	0.0026	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.38e-05	0.00259	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2B—migraine	5.23e-05	0.00251	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	5.23e-05	0.00251	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—HTR7—migraine	5.2e-05	0.0025	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.1e-05	0.00245	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—HTR2A—migraine	5.08e-05	0.00244	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	5.03e-05	0.00242	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CALCRL—migraine	4.99e-05	0.0024	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—RAMP1—migraine	4.99e-05	0.0024	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	4.86e-05	0.00233	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.85e-05	0.00233	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.84e-05	0.00232	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.84e-05	0.00232	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.74e-05	0.00228	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	4.73e-05	0.00227	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.61e-05	0.00222	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CALCRL—migraine	4.53e-05	0.00218	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—RAMP1—migraine	4.53e-05	0.00218	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	4.48e-05	0.00215	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—RAMP1—migraine	4.38e-05	0.0021	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CALCRL—migraine	4.38e-05	0.0021	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	4.31e-05	0.00207	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.26e-05	0.00204	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.25e-05	0.00204	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.25e-05	0.00204	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	4.16e-05	0.002	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.15e-05	0.002	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.05e-05	0.00195	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—RAMP1—migraine	3.98e-05	0.00191	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CALCRL—migraine	3.98e-05	0.00191	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR1B—migraine	3.88e-05	0.00187	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—TAC1—migraine	3.68e-05	0.00177	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—NPS—migraine	3.68e-05	0.00177	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	3.65e-05	0.00175	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CACNA1A—migraine	3.63e-05	0.00175	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR1D—migraine	3.62e-05	0.00174	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR2C—migraine	3.61e-05	0.00173	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—EDNRA—migraine	3.51e-05	0.00169	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR1B—migraine	3.41e-05	0.00164	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.4e-05	0.00163	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CALCA—migraine	3.38e-05	0.00162	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2B—migraine	3.37e-05	0.00162	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR1D—migraine	3.29e-05	0.00158	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR1A—migraine	3.28e-05	0.00158	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—TAC1—migraine	3.23e-05	0.00155	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—NPS—migraine	3.23e-05	0.00155	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR1D—migraine	3.18e-05	0.00153	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2C—migraine	3.17e-05	0.00152	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR7—migraine	3.16e-05	0.00152	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	3.13e-05	0.00151	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—EDNRA—migraine	3.08e-05	0.00148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2B—migraine	3.06e-05	0.00147	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.98e-05	0.00143	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CALCA—migraine	2.97e-05	0.00143	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2B—migraine	2.96e-05	0.00142	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.91e-05	0.0014	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR1D—migraine	2.89e-05	0.00139	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR7—migraine	2.78e-05	0.00133	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2B—migraine	2.69e-05	0.00129	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RAMP1—migraine	2.68e-05	0.00128	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CALCRL—migraine	2.68e-05	0.00128	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.55e-05	0.00123	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CALCRL—migraine	2.35e-05	0.00113	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RAMP1—migraine	2.35e-05	0.00113	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR2A—migraine	2.22e-05	0.00106	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR1B—migraine	2.2e-05	0.00105	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—TNF—migraine	2.18e-05	0.00105	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—NPS—migraine	2.08e-05	0.001	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—TAC1—migraine	2.08e-05	0.001	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2C—migraine	2.04e-05	0.00098	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR1B—migraine	1.99e-05	0.000957	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—EDNRA—migraine	1.99e-05	0.000954	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2A—migraine	1.95e-05	0.000934	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR1D—migraine	1.94e-05	0.000934	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR1B—migraine	1.93e-05	0.000926	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CALCA—migraine	1.91e-05	0.000918	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—TAC1—migraine	1.89e-05	0.000908	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—NPS—migraine	1.89e-05	0.000908	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR1A—migraine	1.86e-05	0.000891	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2C—migraine	1.85e-05	0.00089	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—TAC1—migraine	1.83e-05	0.000878	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—NPS—migraine	1.83e-05	0.000878	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2B—migraine	1.81e-05	0.000868	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—EDNRA—migraine	1.8e-05	0.000866	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2C—migraine	1.79e-05	0.000861	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR7—migraine	1.79e-05	0.000859	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR1B—migraine	1.75e-05	0.000841	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—EDNRA—migraine	1.74e-05	0.000837	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CALCA—migraine	1.74e-05	0.000834	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1D—migraine	1.71e-05	0.00082	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR1A—migraine	1.68e-05	0.000809	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CALCA—migraine	1.68e-05	0.000806	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TAC1—migraine	1.66e-05	0.000797	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—NPS—migraine	1.66e-05	0.000797	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2C—migraine	1.63e-05	0.000782	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR7—migraine	1.62e-05	0.00078	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LRP1—migraine	1.59e-05	0.000764	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2B—migraine	1.59e-05	0.000762	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—EDNRA—migraine	1.58e-05	0.00076	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR7—migraine	1.57e-05	0.000754	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CALCA—migraine	1.52e-05	0.000732	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR7—migraine	1.43e-05	0.000685	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LRP1—migraine	1.4e-05	0.000671	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2A—migraine	1.25e-05	0.000601	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CACNA1A—migraine	1.24e-05	0.000596	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH4—migraine	1.22e-05	0.000586	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—migraine	1.2e-05	0.000577	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR1B—migraine	1.18e-05	0.000566	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2A—migraine	1.14e-05	0.000546	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TAC1—migraine	1.12e-05	0.000536	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PGR—migraine	1.12e-05	0.000536	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NPS—migraine	1.12e-05	0.000536	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2A—migraine	1.1e-05	0.000528	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2C—migraine	1.09e-05	0.000526	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH4—migraine	1.07e-05	0.000515	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EDNRA—migraine	1.07e-05	0.000512	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH3—migraine	1.04e-05	0.000498	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1B—migraine	1.03e-05	0.000497	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CALCA—migraine	1.03e-05	0.000492	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2A—migraine	9.98e-06	0.000479	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1A—migraine	9.95e-06	0.000478	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TAC1—migraine	9.8e-06	0.000471	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NPS—migraine	9.8e-06	0.000471	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PGR—migraine	9.8e-06	0.000471	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2C—migraine	9.61e-06	0.000462	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR7—migraine	9.59e-06	0.000461	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EDNRA—migraine	9.35e-06	0.000449	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH3—migraine	9.11e-06	0.000438	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CALCA—migraine	9e-06	0.000432	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR7—migraine	8.42e-06	0.000404	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TGFBR2—migraine	8.26e-06	0.000397	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CACNA1A—migraine	8.12e-06	0.00039	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TGFBR2—migraine	7.25e-06	0.000348	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—migraine	6.72e-06	0.000323	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ESR1—migraine	5.96e-06	0.000286	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—migraine	5.9e-06	0.000283	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ESR1—migraine	5.23e-06	0.000251	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—migraine	4.11e-06	0.000197	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—migraine	2.69e-06	0.000129	CbGpPWpGaD
